THE SPECIALTY HOSPITAL OF MERIDIAN
1. Target Overview & Investment Thesis
THE SPECIALTY HOSPITAL OF MERIDIAN is a 49-bed community hospital in LAUDERDALE, MS with $10.6M in net patient revenue and a -75.3% operating margin. The hospital serves a payer mix of 94.4% Medicare, 0.0% Medicaid, and 5.6% commercial.
Thesis: Turnaround. Our ML models identify $787K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -75.3% to -67.9% (+741bps).
| Net Revenue HCRIS | $10.6M |
| Current EBITDA COMPUTED | $-8.0M |
| Operating Margin COMPUTED | -75.3% |
| Occupancy HCRIS | 39.8% |
| Revenue / Bed COMPUTED | $217K |
| Net-to-Gross HCRIS | 31.8% |
| Distress Probability ML | nan% |
2. Market Context & Competitive Position
MS has 110 Medicare-certified hospitals with a median operating margin of -12.5%. The target's margin of -75.3% places it below the state median. Among 62 size-comparable peers (24-98 beds), the median margin is -11.7%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (24-98), prioritizing same-state peers. 62 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| THE SPECIALTY HOSPITAL OF MERI (Target) | MS | 49 | $10.6M | -75.3% |
| SOUTHWEST MS REGIONAL MED CENT | MS | 97 | $123.1M | -16.0% |
| BAPTIST MEM HOSPITAL UNION COU | MS | 83 | $117.9M | 3.7% |
| METHODIST H/C OLIVE BRANCH HOS | MS | 65 | $75.4M | -25.6% |
| NORTH SUNFLOWER COUNTY HOSPITA | MS | 25 | $70.1M | -7.2% |
| MISSISSIPPI METHODIST REHAB CE | MS | 31 | $68.1M | -0.5% |
| UMMC-GRENADA | MS | 49 | $63.7M | 7.1% |
| OKTIBBEHA COUNTY HOSPITAL | MS | 88 | $63.2M | -16.5% |
| NESHOBA COUNTY GENERAL HOSPITA | MS | 38 | $47.6M | -19.7% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $787K (741bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $223K | +210bp | 18mo |
| Denial Rate Reduction | 12.0% | 6.5% | $213K | +200bp | 12mo |
| Cost to Collect | 4.5% | 2.5% | $212K | +200bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $129K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $10K | +9bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-8.0M |
| + RCM Uplift | +$787K |
| Pro Forma EBITDA | $-7.2M |
| Current Margin | -75.3% |
| Pro Forma Margin | -67.9% |
| WC Released (1x) | $407K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-12.3M | $-44.9M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-12.3M | $-53.4M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-11.1M | $-54.8M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-11.1M | $-63.1M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-13.5M | $-44.8M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-13.5M | $-53.7M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Heavy Medicare dependence | Medicare comprises 94.4% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 62 hospitals with 24-98 beds
- Same-state prioritization (n=63)
- Comp margins: P25=-22.2% / P50=-11.7% / P75=0.6%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.